Recent developments
Portfolio realignment continues
dsm-firmenich agreed to sell its Animal Nutrition & Health (ANH) business to CVC Capital Partners, retaining a 20% stake and a long‑term vitamins supply agreement; closing is targeted by end‑2026 and an impairment is expected. The company released preliminary figures post‑ANH divestment, reclassifying ANH to discontinued operations and restating continuing activities; Bovaer remains.
Fermentation capacity investments
Evonik is investing about €80 million to add downstream fermentation and processing capabilities at its Fermas site in Slovakia, expanding pharma and animal nutrition bioprocess capacity. IFF is transforming its Arroyito site into the first full fermentation-based enzyme production hub in Latin America, supporting brewing, animal nutrition, biofuels, and home care.
Fertilizer supply plans
Petrobras approved resumption of construction of the UFN III nitrogen fertilizers unit in Três Lagoas, aiming for 3,600 t/d urea and 2,200 t/d ammonia with operations in 2029, to serve domestic crop and livestock markets.
Pricing and demand signals
BASF raises European formic acid prices by €250/MT, affecting feed acidification and hygiene cost structures. Symrise reported Q1 2026 organic sales down 0.4%, with Taste, Nutrition & Health up 1.7%; Pet Food grew low‑single‑digit while Pet Nutrition declined slightly, and full‑year guidance was reaffirmed.
Operations and leadership
Dr Uwe Boltersdorf was appointed as the Chief Operating Officer of BENEO, taking responsibility for operations, supply chain, and HSE while retaining his role at CropEnergies, signaling continued operational focus across specialty ingredients relevant to nutrition markets.